NCT00071994: Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) |
|
|
| Completed | 2 | 59 | US | gefitinib, Iressa, ZD 1839, laboratory biomarker analysis | National Cancer Institute (NCI) | Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer | 05/05 | | | |
